Kevin McCulloch, See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 15,000 shares at $9.41 ($141K) on 2026-10-01, disclosed to the SEC on 2026-10-02.
Scheduled sale ($141k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XERS | SELL | 2026-08-04 | $120K | — | Filing → |
| XERS | SELL | 2026-07-02 | $723K | — | Filing → |
| XERS | SELL | 2026-01-09 | $120K | — | Filing → |